Axsome Therapeutics Ownership | Who Owns Axsome Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Axsome Therapeutics Ownership Summary


Axsome Therapeutics is owned by 79.42% institutional investors, 16.68% insiders, and 3.90% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 9.78% of AXSM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.69% of its assets in Axsome Therapeutics shares.

AXSM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAxsome Therapeutics79.42%16.68%3.90%
SectorHealthcare Stocks 49.65%8.78%41.57%
IndustryBiotech Stocks 46.85%8.74%44.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp4.63M9.78%$373.06M
Vanguard group3.74M7.90%$301.23M
Blackrock3.30M6.96%$265.65M
Fairmount funds management2.36M4.98%$189.99M
Deep track capital, lp1.85M3.91%$149.15M
Macquarie group1.07M2.26%$86.40M
Ra capital management1.00M2.11%$80.50M
Bvf inc/il955.00K2.02%$76.88M
Eventide asset management938.71K1.98%$75.57M
State street938.50K1.98%$75.55M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Alethea capital management740.89K45.25%$59.64M
Fairmount funds management2.36M21.46%$189.99M
Checkpoint capital290.77K14.11%$23.41M
Tri locum partners lp306.51K6.24%$24.67M
Rtw investments, lp4.63M5.78%$373.06M
Deep track capital, lp1.85M4.45%$149.15M
First turn management337.25K4.42%$27.15M
Ghost tree capital150.00K3.78%$12.07M
Iridian asset management llc/ct126.91K2.31%$10.22M
Bvf inc/il955.00K2.15%$76.88M

Top Buyers

HolderShares% AssetsChange
Bvf inc/il955.00K2.15%955.00K
Eventide asset management938.71K1.29%592.00K
Deep track capital, lp1.85M4.45%548.06K
Norges bank404.22K0.00%404.22K
Cormorant asset management, lp400.00K1.86%400.00K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors459.11K0.88%-646.23K
Morgan stanley321.98K0.00%-621.90K
Pictet asset management sa4.29K0.00%-348.07K
Vestal point capital, lp---300.00K
Driehaus capital management---204.70K

New Positions

HolderShares% AssetsChangeValue
Norges bank404.22K0.00%404.22K$32.54M
Cormorant asset management, lp400.00K1.86%400.00K$32.20M
Sofinnova investments310.20K1.30%310.20K$24.97M
Scout investments69.56K0.15%69.56K$5.60M
Abrdn39.67K0.01%39.67K$3.19M

Sold Out

HolderChange
Financial gravity asset management-1.00
Ica group wealth management-10.00
Atticus wealth management-15.00
Systm wealth solutions-16.00
Valley national advisers-20.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202430712.45%38,233,493-6.12%791.08%13115.93%93-1.06%
Jun 30, 2024271-3.21%40,700,3596.09%851.20%112-17.04%9317.72%
Mar 31, 20242806.87%38,362,452-0.55%841.26%13520.54%79-11.24%
Dec 31, 20232627.82%38,574,2922.46%811.10%1121.82%8917.11%
Sep 30, 2023243-3.57%37,647,1043.53%861.23%110-23.08%7638.18%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.30M2.69%-7.92K
Vanguard Small Cap Index1.02M2.11%2.00K
iShares Russell 2000 ETF938.42K1.96%-2.11K
Vanguard Institutional Extnd Mkt Idx Tr607.17K1.25%-2.26K
Delaware Small Cap Core I579.64K1.21%-3.59K
Vanguard Small Cap Growth Index Inv562.39K1.16%-837.00
Bellevue Healthcare Ord506.57K1.06%506.57K
Eventide Healthcare & Life Sciences I497.35K1.04%150.64K
Eventide Gilead N439.57K0.92%439.57K
Fidelity Small Cap Index373.08K0.78%-9.48K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 2024Saad Mark E-Sell$1.01M
Aug 09, 2024Jacobson Mark L. Chief Operating OfficerSell$4.02M
May 29, 2024Jacobson Mark L. Chief Operating OfficerSell$587.81K
May 29, 2024Coleman Mark-Sell$394.33K
May 28, 2024Coleman Mark-Sell$394.77K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3-2
2024 Q2-4
2024 Q1-2
2023 Q4--

AXSM Ownership FAQ


Who Owns Axsome Therapeutics?

Axsome Therapeutics shareholders are primarily institutional investors at 79.42%, followed by 16.68% insiders and 3.90% retail investors. The average institutional ownership in Axsome Therapeutics's industry, Biotech Stocks , is 46.85%, which Axsome Therapeutics exceeds.

Who owns the most shares of Axsome Therapeutics?

Axsome Therapeutics’s largest shareholders are Rtw investments, lp (4.63M shares, 9.78%), Vanguard group (3.74M shares, 7.90%), and Blackrock (3.3M shares, 6.96%). Together, they hold 24.64% of Axsome Therapeutics’s total shares outstanding.

Does Blackrock own Axsome Therapeutics?

Yes, BlackRock owns 6.96% of Axsome Therapeutics, totaling 3.3M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 265.65M$. In the last quarter, BlackRock increased its holdings by 104.5K shares, a 3.27% change.

Who is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested?

Alethea capital management is Axsome Therapeutics’s biggest shareholder by percentage of total assets invested, with 45.25% of its assets in 740.89K Axsome Therapeutics shares, valued at 59.64M$.

Who is the top mutual fund holder of Axsome Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Axsome Therapeutics shares, with 2.69% of its total shares outstanding invested in 1.3M Axsome Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools